Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-CoV-2 proteins and mRNA vaccines
Abstract Background Unlike the injectable vaccines, intranasal lipid nanoparticle (NP)-based adjuvanted vaccine is promising to protect against local infection and viral transmission. Infection of ferrets with SARS-CoV-2 results in typical respiratory disease and pathology akin to in humans, suggest...
Main Authors: | Patricia A. Boley, Carolyn M. Lee, Jennifer Schrock, Kush Kumar Yadav, Veerupaxagouda Patil, Raksha Suresh, Songqing Lu, Maoqi Mark Feng, Juliette Hanson, Rudra Channappanavar, Scott P. Kenney, Gourapura J. Renukaradhya |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-02-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-023-01816-3 |
Similar Items
-
Intranasal boosting with RBD-HR protein vaccine elicits robust mucosal and systemic immune responses
by: Li Chen, et al.
Published: (2024-07-01) -
Mucosal Challenge Ferret Models of Ebola Virus Disease
by: Trevor Brasel, et al.
Published: (2021-03-01) -
The simple guide to ferrets /
by: Land, Babs
Published: (2003) -
SARS-CoV-2 Aerosol and Intranasal Exposure Models in Ferrets
by: Elizabeth E. Zumbrun, et al.
Published: (2023-11-01) -
Treatment of Three Ferrets Diagnosed with Ferret Systemic Coronaviral Disease Using the Nucleoside Analogue GS-441524
by: Julia Puffal, et al.
Published: (2024-03-01)